Cargando…

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model

Recent studies showed that immunological tolerance may restrict the development of Env-specific autoreactive broadly neutralizing antibodies. This evidence is consistent with the finding that Env immunization of a systemic lupus erythematosus (SLE) murine model produced antibodies that neutralize ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siracusano, Gabriel, Finardi, Annamaria, Pastori, Claudia, Martinelli, Vittorio, Furlan, Roberto, Lopalco, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593332/ https://www.ncbi.nlm.nih.gov/pubmed/34795677 http://dx.doi.org/10.3389/fimmu.2021.771359

Ejemplares similares

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Effects of Isoxazolo-Pyridinone 7e, a Potent Activator of the Nurr1 Signaling Pathway, on Experimental Autoimmune Encephalomyelitis in Mice
por: Montarolo, Francesca, et al.
Publicado: (2014)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases
por: Ranzenigo, Martina, et al.
Publicado: (2020)

Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection
por: Siracusano, Gabriel, et al.
Publicado: (2021)

Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis
por: Yin, Jun-Jie, et al.
Publicado: (2017)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis
por: Vigne, Solenne, et al.
Publicado: (2022)

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2017)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
por: McGuire, Andrew T., et al.
Publicado: (2016)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge
por: Borggren, Marie, et al.
Publicado: (2011)

Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies
por: Mohan, Teena, et al.
Publicado: (2018)

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Molecular effects of curcumin on the experimental autoimmune encephalomyelitis
por: Mavaddatiyan, Laleh, et al.
Publicado: (2021)

Effects of Early IL-17A Neutralization on Disease Induction in a Primate Model of Experimental Autoimmune Encephalomyelitis
por: Kap, Yolanda S., et al.
Publicado: (2010)

Systemic Escherichia coli infection does not influence clinical symptoms and neurodegeneration in experimental autoimmune encephalomyelitis
por: Kumar, Prateek, et al.
Publicado: (2015)

Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
por: Kocovski, Pece, et al.
Publicado: (2021)

Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection
por: Mandizvo, Tawanda, et al.
Publicado: (2022)

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Clemente, Nausicaa, et al.
Publicado: (2017)

The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms
por: Morando, Sara, et al.
Publicado: (2012)

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
por: Cantoni, Diego, et al.
Publicado: (2022)

MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis
por: Lecca, Davide, et al.
Publicado: (2016)

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
por: Sanders, Rogier W., et al.
Publicado: (2013)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis
por: Schulz, Martina, et al.
Publicado: (2005)

Mgat5 Deficiency in T Cells and Experimental Autoimmune Encephalomyelitis
por: Grigorian, Ani, et al.
Publicado: (2011)

Translational utility of experimental autoimmune encephalomyelitis: recent developments
por: Guerreiro-Cacais, Andre Ortlieb, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u861aeqo35clell04lngfvrer9